Geode Capital Management, LLC Mirati Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $4.15 Million - $6.16 Million	98,803 Added 11.21%	980,029 $57.6 Million
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $3.25 Million - $5.29 Million	116,743 Added 15.27%	881,226 $38.4 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $1.05 Million - $1.44 Million	29,195 Added 3.97%	764,483 $27.6 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $1.02 Million - $1.52 Million	27,943 Added 3.95%	735,288 $27.3 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $2.12 Million - $5.07 Million	51,395 Added 7.84%	707,345 $32 Million

Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $529,550 - $771,630	8,900 Added 1.38%	655,950 $45.8 Million
Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $341,514 - $773,639	8,721 Added 1.37%	647,050 $43.4 Million
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $1.7 Million - $3.38 Million	22,376 Added 3.63%	638,329 $52.5 Million
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $7.27 Million - $10.5 Million	55,104 Added 9.83%	615,953 $90.4 Million
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $1.1 Million - $1.48 Million	-8,330 Reduced 1.46%	560,849 $99.2 Million
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $26.7 Million - $33.3 Million	-185,457 Reduced 24.58%	569,179 $91.9 Million
Q1 2021 May 12, 2021	BUY	$158.92 - $221.61 $8.88 Million - $12.4 Million	55,901 Added 8.0%	754,636 $129 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $20 Million - $29.7 Million	123,533 Added 21.48%	698,735 $153 Million
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $430,727 - $636,127	3,803 Added 0.67%	575,202 $95.5 Million
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $4.49 Million - $7.51 Million	62,345 Added 12.25%	571,399 $65.2 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $4.71 Million - $7.85 Million	67,561 Added 15.3%	509,054 $39.1 Million
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $804,470 - $1.47 Million	11,369 Added 2.64%	441,493 $56.9 Million
Q3 2019 Nov 12, 2019	BUY	$77.91 - $109.6 $1.35 Million - $1.9 Million	17,323 Added 4.2%	430,124 $33.5 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $2.44 Million - $4.3 Million	41,098 Added 11.06%	412,801 $42.5 Million
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $2.51 Million - $4.54 Million	57,485 Added 18.29%	371,703 $27.2 Million
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $809,376 - $1.2 Million	25,293 Added 8.75%	314,218 $13.3 Million
Q3 2018 Nov 13, 2018	BUY	$47.1 - $62.7 $809,272 - $1.08 Million	17,182 Added 6.32%	288,925 $13.6 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $2.28 Million - $4.58 Million	87,337 Added 47.36%	271,743 $13.4 Million
Q4 2017 Feb 13, 2018	BUY	$12.65 - $19.0 $186,220 - $279,699	14,721 Added 8.68%	184,406 $3.37 Million
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $317,818 - $791,165	67,621 Added 66.25%	169,685 $1.99 Million
Q2 2017 Aug 14, 2017	BUY	N/A	102,064	102,064 $372,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account